Accurate detection of influenza A virus by use of a novel cross-priming isothermal amplification-based point-of-care assay

ABSTRACTInfluenza virus is known to cause respiratory tract infections of varying severity in individuals of all ages. The EasyNAT Rapid Flu assay is a newly developed in vitro diagnostic test that employs cross-priming isothermal amplification (CPA) to detect and differentiate influenza A and B vir...

Full description

Bibliographic Details
Main Authors: Jiankai Deng, Hongji Zhu, Shu An, Hao Huang, Ruizhi Wang, Yaoming Chen, Peisong Chen, Xuegao Yu
Format: Article
Language:English
Published: American Society for Microbiology 2024-03-01
Series:Microbiology Spectrum
Subjects:
Online Access:https://journals.asm.org/doi/10.1128/spectrum.03074-23
_version_ 1797276765018652672
author Jiankai Deng
Hongji Zhu
Shu An
Hao Huang
Ruizhi Wang
Yaoming Chen
Peisong Chen
Xuegao Yu
author_facet Jiankai Deng
Hongji Zhu
Shu An
Hao Huang
Ruizhi Wang
Yaoming Chen
Peisong Chen
Xuegao Yu
author_sort Jiankai Deng
collection DOAJ
description ABSTRACTInfluenza virus is known to cause respiratory tract infections of varying severity in individuals of all ages. The EasyNAT Rapid Flu assay is a newly developed in vitro diagnostic test that employs cross-priming isothermal amplification (CPA) to detect and differentiate influenza A and B viruses in human nasopharyngeal (NP) swabs. The aim of this study is to determine the performance characteristics of the EasyNAT Rapid Flu assay for rapid detection of influenza virus. The limit of detection (LOD) and cross-reactivity of the EasyNAT Rapid Flu assay were assessed. The clinical performance of the assay was evaluated using NP swab samples that were tested with real-time reverse-transcription polymerase chain reaction (RT-PCR) and Xpert Xpress Flu/RSV assay. The LOD for the detection of influenza A and B using the EasyNAT Rapid Flu assay was found to be 500 copies/mL. Furthermore, the assay exhibited no cross-reactivity with other common respiratory viruses tested. For the 114 NP swab samples tested for influenza A using both the EasyNAT Rapid Flu assay and real-time RT-PCR, the two assays demonstrated a high level of agreement (κ = 0.963, P < 0.001), with a positive percentage agreement (PPA) of 97.7% and a negative percentage agreement (NPA) of 98.6%. Similarly, for the 43 NP swab samples tested for influenza A and B using both the EasyNAT Rapid Flu assay and Xpert Xpress Flu/RSV assay, the two assays showed a high level of agreement (κ = 0.933, P < 0.001), with the overall rate of agreement (ORA) of 97.7% for influenza A and 100% for influenza B. The EasyNAT Rapid Flu assay demonstrates excellent performance in the detection of influenza A, highlighted by its strong agreement with RT-PCR-based assays.IMPORTANCEThe newly developed EasyNAT Rapid Flu assay is an innovative cross-priming isothermal amplification-based method designed for detecting influenza A and B viruses at point-of-care settings. This study aims to thoroughly assess the analytical and clinical performance of the assay, offering valuable insights into its potential advantages and limitations. The findings of this research hold significant implications for clinical practice.
first_indexed 2024-03-07T15:33:59Z
format Article
id doaj.art-b1d78d8f16924e5686a263d2e5dc630f
institution Directory Open Access Journal
issn 2165-0497
language English
last_indexed 2024-03-07T15:33:59Z
publishDate 2024-03-01
publisher American Society for Microbiology
record_format Article
series Microbiology Spectrum
spelling doaj.art-b1d78d8f16924e5686a263d2e5dc630f2024-03-05T14:04:36ZengAmerican Society for MicrobiologyMicrobiology Spectrum2165-04972024-03-0112310.1128/spectrum.03074-23Accurate detection of influenza A virus by use of a novel cross-priming isothermal amplification-based point-of-care assayJiankai Deng0Hongji Zhu1Shu An2Hao Huang3Ruizhi Wang4Yaoming Chen5Peisong Chen6Xuegao Yu7Department of Laboratory Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, ChinaDepartment of Laboratory Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, ChinaDepartment of Laboratory Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, ChinaDepartment of Laboratory Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, ChinaDepartment of Laboratory Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, ChinaDepartment of Laboratory Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, ChinaDepartment of Laboratory Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, ChinaDepartment of Laboratory Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, ChinaABSTRACTInfluenza virus is known to cause respiratory tract infections of varying severity in individuals of all ages. The EasyNAT Rapid Flu assay is a newly developed in vitro diagnostic test that employs cross-priming isothermal amplification (CPA) to detect and differentiate influenza A and B viruses in human nasopharyngeal (NP) swabs. The aim of this study is to determine the performance characteristics of the EasyNAT Rapid Flu assay for rapid detection of influenza virus. The limit of detection (LOD) and cross-reactivity of the EasyNAT Rapid Flu assay were assessed. The clinical performance of the assay was evaluated using NP swab samples that were tested with real-time reverse-transcription polymerase chain reaction (RT-PCR) and Xpert Xpress Flu/RSV assay. The LOD for the detection of influenza A and B using the EasyNAT Rapid Flu assay was found to be 500 copies/mL. Furthermore, the assay exhibited no cross-reactivity with other common respiratory viruses tested. For the 114 NP swab samples tested for influenza A using both the EasyNAT Rapid Flu assay and real-time RT-PCR, the two assays demonstrated a high level of agreement (κ = 0.963, P < 0.001), with a positive percentage agreement (PPA) of 97.7% and a negative percentage agreement (NPA) of 98.6%. Similarly, for the 43 NP swab samples tested for influenza A and B using both the EasyNAT Rapid Flu assay and Xpert Xpress Flu/RSV assay, the two assays showed a high level of agreement (κ = 0.933, P < 0.001), with the overall rate of agreement (ORA) of 97.7% for influenza A and 100% for influenza B. The EasyNAT Rapid Flu assay demonstrates excellent performance in the detection of influenza A, highlighted by its strong agreement with RT-PCR-based assays.IMPORTANCEThe newly developed EasyNAT Rapid Flu assay is an innovative cross-priming isothermal amplification-based method designed for detecting influenza A and B viruses at point-of-care settings. This study aims to thoroughly assess the analytical and clinical performance of the assay, offering valuable insights into its potential advantages and limitations. The findings of this research hold significant implications for clinical practice.https://journals.asm.org/doi/10.1128/spectrum.03074-23influenza viruspoint-of-carecross-priming isothermal amplificationreal-time RT-PCRXpert Xpress Flu/RSV assay
spellingShingle Jiankai Deng
Hongji Zhu
Shu An
Hao Huang
Ruizhi Wang
Yaoming Chen
Peisong Chen
Xuegao Yu
Accurate detection of influenza A virus by use of a novel cross-priming isothermal amplification-based point-of-care assay
Microbiology Spectrum
influenza virus
point-of-care
cross-priming isothermal amplification
real-time RT-PCR
Xpert Xpress Flu/RSV assay
title Accurate detection of influenza A virus by use of a novel cross-priming isothermal amplification-based point-of-care assay
title_full Accurate detection of influenza A virus by use of a novel cross-priming isothermal amplification-based point-of-care assay
title_fullStr Accurate detection of influenza A virus by use of a novel cross-priming isothermal amplification-based point-of-care assay
title_full_unstemmed Accurate detection of influenza A virus by use of a novel cross-priming isothermal amplification-based point-of-care assay
title_short Accurate detection of influenza A virus by use of a novel cross-priming isothermal amplification-based point-of-care assay
title_sort accurate detection of influenza a virus by use of a novel cross priming isothermal amplification based point of care assay
topic influenza virus
point-of-care
cross-priming isothermal amplification
real-time RT-PCR
Xpert Xpress Flu/RSV assay
url https://journals.asm.org/doi/10.1128/spectrum.03074-23
work_keys_str_mv AT jiankaideng accuratedetectionofinfluenzaavirusbyuseofanovelcrossprimingisothermalamplificationbasedpointofcareassay
AT hongjizhu accuratedetectionofinfluenzaavirusbyuseofanovelcrossprimingisothermalamplificationbasedpointofcareassay
AT shuan accuratedetectionofinfluenzaavirusbyuseofanovelcrossprimingisothermalamplificationbasedpointofcareassay
AT haohuang accuratedetectionofinfluenzaavirusbyuseofanovelcrossprimingisothermalamplificationbasedpointofcareassay
AT ruizhiwang accuratedetectionofinfluenzaavirusbyuseofanovelcrossprimingisothermalamplificationbasedpointofcareassay
AT yaomingchen accuratedetectionofinfluenzaavirusbyuseofanovelcrossprimingisothermalamplificationbasedpointofcareassay
AT peisongchen accuratedetectionofinfluenzaavirusbyuseofanovelcrossprimingisothermalamplificationbasedpointofcareassay
AT xuegaoyu accuratedetectionofinfluenzaavirusbyuseofanovelcrossprimingisothermalamplificationbasedpointofcareassay